We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.30 | 6.10 | 6.50 | 6.30 | 6.30 | 6.30 | 72,483 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -6.18 | 37.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/12/2022 16:24 | ps. hey strategic, I forgot to mention the other 160 posts which you have also penned on the London South East bulletin board chat forum for Kromek in the last year. between ADVFN and LSE - you have chalked up a very impressive 250 ramps in just the last twelve months. that's a lot of time to spend ramping a share. Care to comment why you do that? ALL IMO. DYOR. QP | quepassa | |
19/12/2022 16:10 | Hey strategic, This is what you wrote a year ago on 26/12/21 in post number 5715 "Definitely my share of the year for 2022 ……" Care to comment about actual performance against expectations and why your choice has proved a dud in terms of share price performance? Because you do spend a lot of time ramping it.... ....to be precise, ninety posts - yes 90 posts - in the last year doing nothing but ramping it. All IMO. DYOR. QP | quepassa | |
19/12/2022 12:42 | Our resident voyeur seems the most likely candidate ALL IMO DYORSP | slicethepie | |
19/12/2022 11:42 | Anyone know the rough average sales price range per unit for the D series detectors. What does 1,000 units equate to in turnover to Kromek ?? | strategicinvestor2 | |
19/12/2022 09:30 | Excellent announcement this morning…. continuous stream of good news | strategicinvestor2 | |
19/12/2022 07:55 | Four RNS contract/agreement announcements in five weeks since 10th. November. FOUR. ha ha ha. ALL IMO. DYOR. QP | quepassa | |
16/12/2022 23:39 | hxxps://news.usni.or Currently a bunch of dogs have more support for investment from Congress in the US, than Kromeks technology. | aqc888 | |
16/12/2022 23:31 | Shame none of the management shared your view and started buying at sub 9p. I did though with a small stake re-entering at 8.5p. Kromek is a weak company with a lot of wind in its sails at the moment. The best thing that could happen here, for all, is that a larger player takes it over. | aqc888 | |
15/12/2022 12:28 | A few small sellers as might be expected. Be good to see fund raising into more positive share price to get over the profit inflection point. Look good now on a lot of fronts. | strategicinvestor2 | |
15/12/2022 11:12 | Hey strategic. You asked a question. My guesses:- 1. Medium-term 8-10p 2. Short term 15p (prior to a potential further fund-raising) Do remember that in their August results announcements they forecast that they were going to breach the NET-DEBT to EDBITDA Banking covenants and that they had to obtain temporary waivers from their Bankers for testing the covenant - up to and including the January test date. We have heard nothing whatsoever about the forecast covenant breach since August. Some possibilities might or might not be: 1. They are now in full compliance with their covenants 2. The three recently announced contracts have contributed to remedying the potential forecast covenant breaches. 3. They need to raise more capital to bring covenant back in line. 4. They may or may not be preparing the ground prior to a fund-raising announcement. I know what I think. Perhaps it may or may not be helpful if there was a market update on the covenant situation as February is very near now. Good Luck All. ALL IMO. DYOR. QP | quepassa | |
15/12/2022 10:11 | For those that haven’t seen it, Released a few days ago: Kromek’s new radiation detection contracts underpin existing forecasts, which included an implicit award of new business, but nevertheless illustrate the increasing interest in its handheld technology, says finnCap. The broker has maintained its forecasts and 27p target price but adds that the interest from government agencies in Kromek's products in the CBRN (nuclear, biohazard) detection segment reflects an increasingly uncertain geopolitical backdrop. “We anticipate the distribution arrangement with Smiths Detection, announced in July, to catalyse increased demand for Kromek’s products, given its size, reputation and international reach. “Equally, we hope to see a second major medical imaging supply contract from an OEM customer during the current financial year, which should drive investor interest and underpin our investment thesis.” Gla | andyview | |
15/12/2022 10:06 | Looks like a golden cross on the one year chart. | share holder | |
15/12/2022 10:05 | andyview I had just watched that :-)) worth 11 minutes of anyones time, Arnab obviously knows his stuff and is a great communicator . | dicktrade | |
15/12/2022 09:49 | Short term target for me is up to 16p. All the positive noises and contracts would suggest a continued rise in the near term. Apologies if already posted; Gla | andyview | |
15/12/2022 09:42 | Possibly a further opportunity: | strategicinvestor2 | |
15/12/2022 09:36 | Agreed share price should move upwards from here hopefully and very strongly with news flow. A funding in this positive background to get past the short term financial inflection point would be good to see. All looking much more positive. IMHO DYOR | strategicinvestor2 | |
15/12/2022 09:26 | My guesses:- 1. Medium-term 8-10p 2. Short term 15p (prior to a potential further fund-raising) Do remember that in their August results announcements they forecast that they were going to breach the NET-DEBT to EDBITDA Banking covenants and that they had to obtain temporary waivers from their Bankers for testing the covenant - up to and including the January test date. We have heard nothing whatsoever about the forecast covenant breach since August. Some possibilities might or might not be: 1. They are now in full compliance with their covenants 2. The three recently announced contracts have contributed to remedying the potential forecast covenant breaches. 3. They need to raise more capital to bring covenant back in line. 4. They may or may not be preparing the ground prior to a fund-raising announcement. I know what I think. Perhaps it may or may not be helpful if there was a market update on the covenant situation as February is very near now. Good Luck All. ALL IMO. DYOR. QP | quepassa | |
15/12/2022 08:46 | Buying yes but very low volumes. Hard to get hold of any decent amount of stock without propelling share price. Still at only 45%!of broker target. Any views on share price in medium term with news flow ?? | strategicinvestor2 | |
14/12/2022 14:52 | Strong buying today. Backed up by a run of positive news flow Gla | andyview | |
14/12/2022 13:53 | Excellent video update now on Proactive | strategicinvestor2 | |
14/12/2022 13:34 | Share price 130% below this weeks Broker immediate target | strategicinvestor2 | |
14/12/2022 11:31 | Looking sprightly again Gla | andyview | |
12/12/2022 18:39 | Yes haven’t seen any contract values being quotes associated with this activity ?? | strategicinvestor2 | |
12/12/2022 16:51 | the recent announcement about Spectrum Dynamics using Kromeks CZT camera modules in their latest design is not factored into the share price in my opinion. This article shows they have other products that are CZT based and it's hard to image Kromek wouldn't be now supplying for these to. So some news here due soon I think. Spectrum Dynamics | KeV Medical Imaging. | 33mick |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions